Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003468177 | SCV004197212 | likely pathogenic | Fanconi anemia complementation group I | 2024-03-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV005100164 | SCV005811478 | pathogenic | Fanconi anemia | 2024-02-25 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr699*) in the FANCI gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FANCI are known to be pathogenic (PMID: 17452773, 17460694). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with FANCI-related conditions. For these reasons, this variant has been classified as Pathogenic. |